By Dr Lisa Mary Raven

Conference Abstracts

Jeyakumar S; Jeyakumar R; Robson D; Honeysett L; Raven L; Deveza e Silva RC; Jabbour A; Kotlyar E; Keogh A; Greenfield J; MacDonald P; Hayward C; Muthiah K, 2024, '(199) Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in End-Stage Heart Failure Patients Considered for Heart Transplantation', in The Journal of Heart and Lung Transplantation, Elsevier, Vol. 43, pp. s106, http://dx.doi.org/10.1016/j.healun.2024.02.213

Raven LM; Muir CA; Iglesias CK; Bart NK; Muthiah K; Kotlyar E; Hayward CS; Macdonald PS; Jabbour A; Greenfield JR, 2024, '(287) Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation', in The Journal of Heart and Lung Transplantation, Elsevier, Vol. 43, pp. s148 - s149, http://dx.doi.org/10.1016/j.healun.2024.02.302

Muir CA; Raven LM; Goodall L; Center JR, 2023, 'THU441 Teriparatide As Treatment For Severe Osteoporosis In Lung Transplant Recipients', in Journal of the Endocrine Society, The Endocrine Society, Vol. 7, pp. bvad114.402, http://dx.doi.org/10.1210/jendso/bvad114.402

Chavali S; Barua S; Adjii A; Robson D; Raven L; Greenfield J; Parvar S; MacDonald P; Hayward C; Muthiah K, 2023, 'Safety and Tolerability of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Patients Supported with Left Ventricular Assist Devices', in The Journal of Heart and Lung Transplantation, Elsevier, Vol. 42, pp. s450 - s451, http://dx.doi.org/10.1016/j.healun.2023.02.1253

Back to profile page